Genelux Corporation Share Price
NASDAQ: GNLX | Micro CapGenelux Corporation Stock Performance
Genelux Corporation Share Price Today
As of 11 October 2026, Genelux Corporation's share price is $2.57. The stock opened at $2.54, compared to its previous close of $2.50. During today's trading session, Genelux Corporation's share price traded between $2.48 and $2.56, with an average price of $2.52. Over the past 52 weeks, the stock has recorded a high of $8.46 and a low of $2.29. In terms of performance, Genelux Corporation's share price has declined by 3.56% over the last six months and is down 68.15% on a year-on-year basis.
Genelux Corporation Share Price Chart
Genelux Corporation Quarterly Profit & Loss
All figures in USD
Genelux Corporation Annual Profit & Loss
All figures in USD
About Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Genelux Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.48 | $2.56 | +0.99% |
Sep 2026 | $2.58 | $2.53 | -12.15% |
Aug 2026 | $2.96 | $2.88 | -1.87% |
Jul 2026 | $3.01 | $2.94 | -2.81% |
Jun 2026 | $3.00 | $3.02 | -1.31% |
May 2026 | $2.67 | $3.06 | +14.82% |
Apr 2026 | $2.48 | $2.67 | +10.58% |
Mar 2026 | $2.84 | $2.41 | -19.13% |
Feb 2026 | $2.73 | $2.98 | +11.61% |
Jan 2026 | $4.54 | $2.67 | -38.69% |
Dec 2025 | $5.25 | $4.36 | -22.30% |
Nov 2025 | $7.92 | $5.61 | -30.55% |